Aitziber Buqué

11.0k citations
65 papers · 8.9k · 6 hit papers · h-index 32

Impact in

  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Immune cells in cancer
    • Phagocytosis and Immune Regulation
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Immunotherapy and Immune Responses 23
    • Immune Cell Function and Interaction 15
    • Phagocytosis and Immune Regulation 6
    • Cancer Immunotherapy and Biomarkers 23
    • CAR-T cell therapy research 8
    • Cancer-related Molecular Pathways 7

Aitziber Buqué

61 papers receiving 8.7k citations

Aitziber Buqué's Hit Papers

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients 2025 · 34 citations
340+4+8Years since publication50010001.5k2.0k2.5k

Peers

Aitziber Buqué
Comparison fields: 5 of 121
  • Immunology 4.0k
  • Oncology 3.9k
  • Physiology 254
  • Cancer Research 587
  • Biotechnology 361
Replace Jitka Palich Fucikova with:
Jitka Palich Fucikova Czechia
Radek Špíšek Czechia
Michel Obéid Switzerland
Chrystal Mary Paulos United States
Evelyn Ullrich Germany
Brian Ruffell United States
Caius G. Radu United States
Antoine Tesnière France
Elaine Y. Lin United States
Christina Pfirschke United States
Aitziber Buqué relative to Jitka Palich Fucikova Czechia Jitka Palich Fucikova's profile →
Citations per field
00.5×1.5×
Jitka Palich Fucikova · 1×
Citations per year

Countries citing papers authored by Aitziber Buqué

Since Specialization
Citations

This map shows the geographic impact of Aitziber Buqué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aitziber Buqué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aitziber Buqué more than expected).

Fields of papers citing papers by Aitziber Buqué

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aitziber Buqué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aitziber Buqué. The network helps show where Aitziber Buqué may publish in the future.

Co-authors

The 25 scholars most cited alongside Aitziber Buqué, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aitziber Buqué Line = papers co-authored together Aitziber Buqué links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Immunogenic cell death in cancer and infectious disease
Hit paper breakdown →
20162507
2
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Hit paper breakdown →
20151281
3
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Hit paper breakdown →
20201067
4
Consensus guidelines for the detection of immunogenic cell death
Hit paper breakdown →
2014719
5
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
Hit paper breakdown →
2016440
6 2014378
7 2020282
8 2020171
9 2022120
10 2019116
11 2015110
12 2015109
13 2015106
14 2020104
15 2015103
16 201598
17 202097
18 201791
19 201669
20 201868

About Aitziber Buqué

Aitziber Buqué is a scholar working on Immunology, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Biotechnology, having authored 65 papers that have together received 8.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (23 papers), Immunotherapy and Immune Responses (23 papers), Immune Cell Function and Interaction (15 papers), CAR-T cell therapy research (8 papers), Cancer-related Molecular Pathways (7 papers), Autophagy in Disease and Therapy (6 papers), Advanced Breast Cancer Therapies (6 papers) and Phagocytosis and Immune Regulation (6 papers). The work is most often cited by research in Immunology (4.0k citations), Oncology (3.9k citations), Physiology (254 citations), Cancer Research (587 citations) and Biotechnology (361 citations). Aitziber Buqué has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Lorenzo Galluzzi, Guido Kroemer, laurence ZITVOGEL, Oliver Kepp, Juliette F Humeau, Norma Bloy, Giulia Petroni, Takahiro Yamazaki, Jitka Palich Fucikova and Alexander M.M. Eggermont. Their work appears in journals such as OncoImmunology, Nature reviews. Immunology, Cancer Cell, Trends in cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact